Seer (SEER) Return on Capital Employed (2021 - 2026)
Seer (SEER) recorded quarterly Return on Capital Employed of 27.21% in Q1 2026, little changed quarter-over-quarter from 27.21% in Q4 2025, and down 2322.0% on a YoY basis from 1.22% in Q1 2025.
Seer (SEER) Return on Capital Employed (2021 - 2026) Analysis & Trends
Seer's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 27.21% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 2322.0% year-over-year to 27.21%; the TTM figure through Mar 2026 stood at 27.21% (down 2322.0% YoY), while the FY2025 annual figure was 24.71%, down 2000.0% from the prior year.
- Return on Capital Employed was 27.21% for Q1 2026 at Seer, roughly flat from 27.21% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.72% in Q3 2025 to a low of 27.21% in Q1 2026.
- Historically, Return on Capital Employed has averaged 13.03% across 5 years, with a median of 15.09% in 2022.
- The sharpest annual moves came in 2024 and 2026: Return on Capital Employed jumped 2056 bps in 2024, then tumbled 2322 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 20.19% in 2022, then jumped by 79 bps to 4.24% in 2023, then declined by 19 bps to 5.05% in 2024, then sank by 439 bps to 27.21% in 2025, then dropped by 0 bps to 27.21% in 2026.
- The last three Return on Capital Employed figures came in at 27.21% (Q1 2026), 27.21% (Q4 2025), and 0.72% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -107.40% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -50.43% |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -27.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.21% |
| Dec 31, 2025 | -27.21% |
| Sep 30, 2025 | -0.72% |
| Jun 30, 2025 | -2.21% |
| Mar 31, 2025 | -3.99% |
| Dec 31, 2024 | -5.05% |
| Sep 30, 2024 | -3.55% |
| Jun 30, 2024 | -3.78% |
| Mar 31, 2024 | -3.81% |
| Dec 31, 2023 | -4.24% |
| Sep 30, 2023 | -24.10% |
| Jun 30, 2023 | -23.36% |
| Mar 31, 2023 | -21.53% |
| Dec 31, 2022 | -20.19% |
| Sep 30, 2022 | -18.63% |
| Jun 30, 2022 | -16.88% |
| Mar 31, 2022 | -15.09% |
| Dec 31, 2021 | -13.74% |
| Sep 30, 2021 | -12.36% |
| Jun 30, 2021 | -10.25% |